C-MER Eye Care Holdings Limited (3309.HK)

HKD 1.96

(-1.01%)

Market Cap (In HKD)

2.41 Billion

Revenue (In HKD)

1.92 Billion

Net Income (In HKD)

61.99 Million

Avg. Volume

1.46 Million

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.81-3.48
PE
-
EPS
-
Beta Value
0.615
ISIN
KYG2R51A1053
CUSIP
G2R51A105
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Dr. Shun Chiu Lam J.P.
Employee Count
-
Website
https://www.cmereye.com
Ipo Date
2018-01-15
Details
C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates eye and surgery centers, and satellite clinics that provide cataract and intraocular lens implant, refractive correction, corneal and external eye disease, glaucoma, vitreo-retinal disease, oculoplastic and orbital disease, and squint and pediatric ophthalmology services. It also sells vision aid and pharmaceutical products, as well as dental services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.